To study the effect of kashaya and snehana and swedana at chest region in the treatment of bronchial asthma

Phase 2

• Conditions: Health Condition 1: J00-J99- Diseases of the respiratory system

• Registration Number: CTRI/2021/08/036014
• Lead Sponsor: DrJayanti Dutta

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Duration not more than 2years

2. History of intermittent or persistent asthma symptoms. FEV1 between 50% to 85% of predicted value.

3. Non-smoker/left smoking past 3 months.

4.Pre bronchodilator FEVI1 values in range of 60-80%

5. Normal SGPT and serum creatinine

Exclusion Criteria

1.Smoking

2. Active upper respiratory tract infection within 3 weeks

3. Acute sinus disease requiring antibiotic treatment within 1 week therapy, inhaled

4. Medications: Warfarin, anti-platelet

month.

or parental corticosteroid within 1

5. Patient receiving immunotherapy 6 months before pre-study visit

6. Pregnant females, patients suffering from concurrent systemic disease like cardiopulmonary, diarrheal

T.B., bronchiectasis, CHF, hepatic dysfunction, neurological disorders, and disorders or having hemoglobin less than 10 g/dl

7. Patient having complications like CCF, Cor-pulmonale, Emphysema, Pneumonia,

Malignancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified